Published July 15, 2006 | Version v1
Journal article

Expression of the p73 protein in rectal cancers with or without preoperative radiotherapy

  • 1. Department of Oncology, Institute of Biomedicine and Surgery, Linkoeping University, Linkoeping (Sweden)

Description

Purpose: To investigate p73 expression in normal mucosa, primary tumor, and metastasis in relation to radiotherapy (RT) response and clinicopathologic/biologic variables in rectal cancers. Methods and Materials: p73 was immunohistochemically examined on biopsies (unirradiated, n = 102), distant (from the large bowel, n = 82), and adjacent (adjacent to primary tumor, n = 89) normal mucosa samples, primary tumors (n = 131), and lymph node metastasis (n = 32) from rectal cancer patients participating in a clinical trial of preoperative RT. Seventy-four patients received surgery alone and 57 received additional RT. Results: Cytoplasmic p73 was increased in the primary tumor compared with the distant or adjacent mucosa (p ≤ 0.0001). Nuclear (p = 0.02) and cytoplasmic (p = 0.003) p73 was higher in irradiated distant mucosa samples than in unirradiated ones, and nuclear p73 tended to be increased in irradiated primary tumors compared with unirradiated ones (p = 0.06). p73 was positively related to cyclooxygenase-2 expression in irradiated tumors (p = 0.03). p73-negative tumors tended to have a lower local recurrence after RT compared with unirradiated cases (p 0.06). Conclusions: Normal epithelial cells seem more sensitive to RT than tumor cells regarding p73 expression. Patients with p73-negative rectal tumors may have a lower risk of local recurrence after RT

Additional details

Identifiers

DOI
10.1016/j.ijrobp.2006.02.028;
PII
S0360-3016(06)00385-3;

Publishing Information

Journal Title
International Journal of Radiation Oncology, Biology and Physics
Journal Volume
65
Journal Issue
4
Journal Page Range
p. 1143-1148
ISSN
0360-3016
CODEN
IOBPD3

INIS

Country of Publication
United States
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
38020450
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Descriptors DEI
BIOPSY; CLINICAL TRIALS; HEALTH HAZARDS; IRRADIATION; LYMPH NODES; METASTASES; MUCOUS MEMBRANES; NEOPLASMS; PATIENTS; PROTEINS; RADIOTHERAPY; SURGERY; TUMOR CELLS
Descriptors DEC
ANIMAL CELLS; DIAGNOSTIC TECHNIQUES; DISEASES; HAZARDS; LYMPHATIC SYSTEM; MEDICINE; MEMBRANES; NUCLEAR MEDICINE; ORGANIC COMPOUNDS; RADIOLOGY; TESTING; THERAPY

Optional Information

Copyright
Copyright (c) 2006 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.